Therapy News and Research

RSS

Individual cognitive therapy effective in relieving PTSD symptoms in active-duty military members

Although both group and individual therapy can ease post-traumatic stress disorder (PTSD) symptoms in active-duty military service members, individual therapy relieved PTSD symptoms better and quicker, according to a study led by a Duke University School of Medicine researcher.

23 Nov 2016

Scientists develop new technology that sheds light on HIV infection

A group of researchers at the Centre for Genomic Regulation and the Pompeu Fabra University in Barcelona, Spain, have developed a new technology that sheds light on the HIV infection and offers a first glance at the expression landscape of the HIV in the human genome.

23 Nov 2016

ADVANCECAT enables development of advanced therapies to benefit Catalan health system

Enabling the arrival of advanced therapies from pre-clinical stages to industrial production and clinical application: this is the objective of ADVANCECAT project, led by the University of Barcelona and Ferrer, and build up by eighteen entities of the health field in which there are two universities, twelve biomedical research institutes or private foundations, and four companies.

23 Nov 2016

ADD Program receives $19.5 million NIH contract to test drugs for treating epilepsy

The University of Utah College of Pharmacy's Anticonvulsant Drug Development Program has been awarded a five-year $19.5 million contract renewal with the National Institutes of Health to test drugs to treat epilepsy, and the major focus of the project is to address needs that affect millions of people worldwide -identify novel investigational compounds to prevent the development of epilepsy or to treat refractory, or drug-resistant, epilepsy.

23 Nov 2016

Therapy Road offers quick and easy way to find mental health professionals

Finding a therapist that fits best with your personality and your specific needs is now quick, easy, and can be done from the comfort of your own home.

23 Nov 2016

IQWiG finds colorectal cancer drug combination has added benefit only for some patients

The fixed combination of trifluridine/tipiracil has been approved since April 2016 for the treatment of metastatic colorectal cancer.

23 Nov 2016

Researcher to examine if music intervention can alleviate distress in young cancer patients and parents

An Indiana University School of Nursing researcher has been awarded $1.4 million to determine if a music therapy intervention can be used to manage acute distress in young cancer patients ages 3 to 8 and their parents.

22 Nov 2016

Melanoma drug offers considerable added benefit for patients with advanced NSCLC

Pembrolizumab was initially introduced for the treatment of melanoma. Since July 2016, the monoclonal antibody has also been available for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) in adults whose tumours express the T-cell receptor ligand PD-L1 and who have received a prior chemotherapy regimen.

22 Nov 2016

New combinatination therapy shows promise in treating patients with traumatic brain injury

A combination of the stimulant drug methylphenidate with a process known as cognitive-behavioral rehabilitation is a promising option to help people who suffer from persistent cognitive problems following traumatic brain injury, researchers at Indiana University School of Medicine have reported.

22 Nov 2016

Penn study shows breathing-based meditation can help alleviate severe depression

A breathing-based meditation practice known as Sudarshan Kriya yoga helped alleviate severe depression in people who did not fully respond to antidepressant treatments, reports a new study published today in the Journal of Clinical Psychiatry from researchers in the Perelman School of Medicine at the University of Pennsylvania.

22 Nov 2016

Allergan gets FDA approval for new XEN Glaucoma Treatment System

Allergan plc announced today the U.S. Food and Drug Administration has cleared the XEN Glaucoma Treatment System (consisting of the XEN45 Gel Stent and the XEN Injector) for use in the U.S.

22 Nov 2016

Study highlights potential to develop antiviral therapies, vaccines for treating astroviruses

Human astroviruses infect nearly everyone during childhood, causing diarrhea, vomiting, and fever.

22 Nov 2016

EPFL scientists discover cause for immune attack in type-1 diabetes

Type-1 diabetes occurs when immune cells attack the pancreas. EPFL scientists have now discovered what may trigger this attack, opening new directions for treatments.

21 Nov 2016

Study shows new drug combination effective in treating precancerous skin lesions

A combination of two topical drugs that have been in use for years triggers a robust immune response against precancerous skin lesions, according to a new study. The research, from Washington University School of Medicine in St. Louis and Harvard Medical School, shows that the therapy activates the immune system's T cells, which then attack the abnormal skin cells.

21 Nov 2016

Study uncovers mechanism that causes chemo resistance of pancreatic cancer cells

A pioneering University of Liverpool research team have published a study that identifies the mechanism in the human body that causes resistance of pancreatic cancer cells to chemotherapy.

21 Nov 2016

OrbusNeich launches new Dual Therapy Stent for active vessel healing

OrbusNeich has announced the launch of its latest generation Dual Therapy Stent (DTS), the COMBO Plus.

21 Nov 2016

Nature article highlights use of QGel's designer matrices for intestinal and colorectal cancer organoid culture

Nature, the leading weekly international scientific journal, yesterday reported the first intestinal and colorectal cancer organoid culture in fully defined extra cellular matrices (ECM).

21 Nov 2016

MEDICA and COMPAMED 2016 offer excellent platform for global business relationships in medical technology industry

Once again, the world’s biggest medical trade fair MEDICA and the leading international supplier trade fair COMPAMED, which take place in Düsseldorf, have provided a powerful stimulus for the international medical technology industry.

21 Nov 2016

Multi-disciplinary care in patients with CKD likely to be cost effective intervention, study finds

Coordination of care designed to slow the progression of kidney disease is likely to be cost effective because it prevents the need for dialysis, according to a study that will be presented at ASN Kidney Week 2016 November 15¬-20 at McCormick Place in Chicago, IL.

21 Nov 2016

Results of high-impact clinical trials could improve kidney-related medical care

The results of numerous high-impact clinical trials that could affect kidney-related medical care will be presented at ASN Kidney Week 2016, November 15-20 at McCormick Place in Chicago, IL.

21 Nov 2016

Therapy News and Research

Individual cognitive therapy effective in relieving PTSD symptoms in active-duty military members

Scientists develop new technology that sheds light on HIV infection

ADVANCECAT enables development of advanced therapies to benefit Catalan health system

ADD Program receives $19.5 million NIH contract to test drugs for treating epilepsy

Therapy Road offers quick and easy way to find mental health professionals

IQWiG finds colorectal cancer drug combination has added benefit only for some patients

Researcher to examine if music intervention can alleviate distress in young cancer patients and parents

Melanoma drug offers considerable added benefit for patients with advanced NSCLC

New combinatination therapy shows promise in treating patients with traumatic brain injury

Penn study shows breathing-based meditation can help alleviate severe depression

Allergan gets FDA approval for new XEN Glaucoma Treatment System

Study highlights potential to develop antiviral therapies, vaccines for treating astroviruses

EPFL scientists discover cause for immune attack in type-1 diabetes

Study shows new drug combination effective in treating precancerous skin lesions

Study uncovers mechanism that causes chemo resistance of pancreatic cancer cells

OrbusNeich launches new Dual Therapy Stent for active vessel healing

Nature article highlights use of QGel's designer matrices for intestinal and colorectal cancer organoid culture

MEDICA and COMPAMED 2016 offer excellent platform for global business relationships in medical technology industry

Multi-disciplinary care in patients with CKD likely to be cost effective intervention, study finds

Results of high-impact clinical trials could improve kidney-related medical care

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News